The firm upgraded shares of the health care giant to buy from neutral and raised its target price to $640 from $520.
You are here: Home / UBS upgrades this ‘core’ health care stock, sees nearly 20% upside
Market News and Views
The firm upgraded shares of the health care giant to buy from neutral and raised its target price to $640 from $520.